EVLA - EndoVenous Laser Ablation of Varicose Veins:
Endovenous
laser ablation (EVLA) was invented following a discussion by 3 doctors
at a venous meeting in 1998:
Dr Carlos Boné from
Spain
Dr Luis Navarro from the USA
Dr Robert Min from
the USA
(Endovenous laser: a new minimally
invasive method of treatment for varicose veins--preliminary observations
using an 810 nm diode laser. Navarro L, Min RJ, Boné C
Dermatol Surg. 2001 Feb;27(2):117-22 -
click here to see abstract)
It had become clear that heating a vein with sufficient energy to
destroy it, cause the vein to shrivel away and cause a permanent
closure. Therefore the vein did not need to be removed - closing it
gave the same result.
Both stopped the refluxing flow of blood back down the vein, therefore
both stopped the damage that caused varicose veins and the
complications of itching, thrombophlebitis, venous eczema, red and
brown staining of the skin, bleeding and leg ulcers.
Initially EVLT®
was the only technique that allowed laser to be introduced into the
vein to destroy it. However many other companies have now produced
different laser techniques to do the same job, using different
wavelengths of laser, different introduction in techniques and even
different ways the energy is fired out of the end of the laser fibre.
Therefore although some people still use the term EVLT®
to mean laser treatment of varicose veins, in fact EVLT®
is a registered trademark that only refers to one product. It is much
more correct to use the term EVLA - endovenous laser ablation - when
talking about a different techniques that are available.
Although there are different techniques
of performing EVLA, the general principles are the same for all
different techniques.
Using duplex ultrasound, a needle is passed into the vein under local
anaesthetic. A wire is passed up the vein, once again under ultrasound
control to make sure it is in exactly the right place.
A long sheath (like a very long biro refill) is then passed up over
the wire - a technique called the "Seldinger technique".
When the vein is destroyed, the inside the vein can reach 700°C
although the outside is usually much cooler than this. However to
prevent any pain and to stop any heat burning any surrounding tissues,
a very dilute solution of local anaesthetic and normal saline is
injected around the vein. Ultrasound is used to make sure it is in
exactly the right place. This is called tumescent anaesthesia.
The laser fibre can now be passed up
inside the sheath. It was research from The Whiteley Clinic that
showed that it was important to put the tumescence in before passing
the fibre up, to make sure the fibre was not damaged by the
anaesthetic needle. This research was one of the many prizes won by
The Whiteley Clinic in the development of these techniques.
Once the ultrasound shows the laser fibre is in exactly the right
place, the laser is fired and the sheath and fibre is pulled down at
exactly the right speed, closing the vein at a precise energy level.
Research is showing that 60 - 80 Joules per cm of vein will destroy
the vein but will cause minimal pain and bruising.
Using EVLA in the veins identified as
being suitable by Whiteley Clinic protocols, using The Whiteley Clinic
techniques, allows us to permanently destroy appropriate veins using
one pinhole incision for each vein.
Our research has shown that the best results come from treating not
only the main vein, but in at least a third of people we need to treat
at least one additional vein.
There are new EVLA procedures coming, and The Whiteley Clinic is
involved in research with some and is trialling others to make sure
that we keep offering patients the very best available treatments.
Unlike stripping, EVLA in our hands has not ever shown any re-growth
of veins even after five years. You can contrast these results with
the re-growth found after one year on the vein stripping part of this
website.
EVLA in suitable patients really allows true walk-in walk-out varicose
vein surgery, and when combined with other appropriate techniques
gives us the excellent results that our patients require.